 Joan Houghton |
 Elizabeth Barrett-Connor |
 Fran Balkwill |
 Carl Christophe Schimanski |
…
 John Neoptolemos |
 Wilko Weichert |
 Christophe Nemos |
…
 David Cunningham |
 Kenneth MacDonald |
 Mark Pomerantz |
 Jorge Garcia |
…
 Arlene Forastiere |
 Everett Vokes |
 Michael Skinner |
 Mark Chambers |
…
 Robert Ozols |
 Lawrence Wickerham |
 Patricia Ganz |
 Jorma Paavonen |
 Noah Kauff |
Robert Ozols of the Fox Chase Cancer Center in Philadelphia joins Derek Thorne to talk about the top presentations on cancer prevention.
- Raloxifene is as good as tamoxifen at
…
 Robert Mayer |
 Thierry Facon |
 Ibrahim Yakoub-Agha |
 Peter Paschka |
Robert Mayer of the Dana-Farber Cancer Institute in Boston joins Derek Thorne to discuss the major hematologic malignancy news reported at the 2006 ASCO meeting.
- Older patients with multiple myeloma can
…
 Dean Bajorin |
 Robert Motzer |
 Gary Hudes |
 Marshall Posner |
Some major progress in kidney cancer and head and neck cancer was announced at the ASCO meeting in Atlanta, and the Audio Journal of Oncology has all the details, plus expert comment
…
 Julie Gralow |
 Charles Geyer |
 Judith Bliss |
 Robert Coleman |
Julie Gralow, from the Fred Hutchinson Cancer Research Center in Seattle, joins Derek Thorne to talk about the latest news from the ASCO annual meeting in Atlanta.
- In women with
…
 George Canellos |
 Carmela Pepe |
 John Goldman |
 Roy Herbst |
 Sandra Horning |
|
- Elderly patients
…
…
Reporting from:
American Society of Hematology Meeting, Atlanta, 10-13 December 2005
In this edition:
It is not necessary to use rituximab along with standard CVP (cyclophosphamide, vincristine, predinsone) induction therapy among patients with advanced follicular lymphoma. So said Sandra Horning …
Reporting from:
- San Antonio Breast Cancer Symposium 2005
In this edition:
The targeted drug trastuzumab may be used in place of anthracyclines for breast adjuvant chemotherapy regimens, according to the findings of Dennis Slamon, who announced the BCIRG 006 …